Diamond Wellness Holdings, Inc.

CIK:0001746563|SEC Filings

INCOME STATEMENT - USD ($)	12 Months Ended
INCOME STATEMENT - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Revenue
Sales	$ 9,680,543	$ 15,060,840
Cost of goods sold	6,252,339	10,244,236
Gross profit	3,428,205	4,816,604
Operating expenses
Research and development	0	0
Freight Out and Merchant Account Charges	1,891,757	1,948,505
Advertising and Marketing	1,490,713	4,109,951
General & Admin Expenses (see Note 17)	1,405,884	1,791,840
Officers' Compensation	142,400	130,000
Total operating expenses	4,930,753	7,980,296
Financing expenses
Interest Expense	374,623	334,139
Total financing expenses	2,871	1,408
Total Expenses	5,305,376	8,314,435
Profit (Loss) from continuing operations	(1,877,171)	(3,497,831)
Profit (Loss) from nonrecurring items
Loss from Debt Settlements by share issuances	(695,048)	0
Impairment Loss - Advances to Drop Shipper [non-recurring]	(3,012,449)	0
Total nonrecurring items	(3,707,497)	0
Profit (Loss) from continuing operations and non-recurring items	(5,584,669)	(3,497,831)
Provision for Income Tax	0	0
Total Net Profit (Loss)	$ (5,584,669)	$ (3,497,831)
Earnings per share
Earnings per share (based on Profit (Loss) before Income Tax	$ (0.00224)	$ (0.00499)
Basic and diluted (based on Profit (Loss) before Income Tax	(0.00224)	(0.00499)
Earnings per share (based on Profit (Loss) After Income Tax	(0.00668)	(0.00499)
Basic and diluted (based on Profit (Loss) After Income Tax	$ (0.00668)	$ (0.00499)
Basic and diluted weighted average common shares outstanding	836,260,638	700,836,384

CASH FLOWS STATEMENT - USD ($)	12 Months Ended
CASH FLOWS STATEMENT - USD ($)	Dec. 31, 2020	Dec. 31, 2019
CASH FLOWS STATEMENT
Net Income (Loss)	$ (5,584,669)	$ (3,497,831)
Adjustments to reconcile net income (loss)
Advances & Accounts Receivable	2,261,592	(1,294,207)
Impairment (see "Notes on Accounts" Note 15)	3,012,449
Payable	(1,051,963)	1,192,467
Total Adjustments to reconcile net income (loss)	4,222,079	(101,741)
Net cash from the current year operations	(1,362,590)	(3,599,572)
Investing
Common Stock	1,069,368	826,800
Preferred A Stock		0
Additional Capital		1,626,589
Net cash provided by investing activities	1,069,368	2,453,389
Financing
Third Party Loan	(22,589)	2,560
EIDL Loan from SBA	153,051	0
PPP Loan from SBA	136,291	0
Notes Payable	(3,547)	629,779
Net cash provided by financing activities	263,206	632,339
Net change in cash and cash equivalents	(30,016)	(513,844)
Cash and cash equivalents, beginning of period	70,581	584,425
Cash and cash equivalents, end of period	$ 40,565	$ 70,581

BALANCE SHEET - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current Assets
Cash/Bank Balances	$ 40,565	$ 70,581
Accounts Receivable
from Customers	20,054	325,305
from others	649,312	649,312
Total Accounts Receivable	669,366	974,617
Advances - Drop Shipper (Year End Balance)	3,012,449	5,070,696
Impairment (see "Notes on Accounts" Note 15)	(3,012,449)	0
Prepaid Expenses	0	9,000
Total Current assets	709,931	6,124,894
TOTAL ASSETS	709,931	6,124,894
Current Liabilities
Payables	502,299	1,673,501
Short term loan (Kabbage) with accrued interest	8,333
Total Current Liabilities	510,632	1,673,501
Long-term Liabilities
Loan from 3rd Party with accrued interest	18,372	40,960
SBA Loans with accrued interest	289,342
Note Payable	4,188,991	4,192,539
Total Long-term liabilities	4,496,705	4,233,499
Total Liabilities	5,007,338	5,907,000
Stockholders' Equity
Common: Authorized 1,500,000,000 shares, $ .00001 par value; and 836,260,638 Issued and outstanding as of December 31, 2020 and 700,836,384 shares, Issued and outstanding as of December 31, 2019	5,065,208	3,995,840
Preferred Stock Class A Authorized - 50,000 shares, $ .00001 Par value; and 34,289 Issued and outstanding, as of December 31, 2020 and 34,289 issued and outstanding as of December 31, 2019	400	400
Additional Paid-in Capital	1,626,589	1,626,589
Retained Earnings	(10,989,604)	(5,404,935)
Total Stockholders' Equity	(4,297,407)	217,894
Total Liabilities & Equity	$ 709,931	$ 6,124,894